Human disease
melanoma
Mondo defines it as: “A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 1724 | Melanoma, malignant | The group's name | 6 | Human disease |
37.5
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Binimetinib | None of these genes | Approved |
| Cobimetinib | None of these genes | Approved |
| Dabrafenib | None of these genes | Approved |
| Dacarbazine | None of these genes | Approved |
| Encorafenib | None of these genes | Approved |
| Hydroxyurea | None of these genes | Approved |
| Interferon Alfa-2b | None of these genes | Approved |
| Ipilimumab | None of these genes | Approved |
| Nivolumab | None of these genes | Approved |
| Peginterferon Alfa-2b | None of these genes | Approved |
| Pembrolizumab | None of these genes | Approved |
| Relatlimab | None of these genes | Approved |
| Talimogene Laherparepvec | None of these genes | Approved |
| Tebentafusp | None of these genes | Approved |
| Technetium Tc 99m Sulfur Colloid | None of these genes | Approved |
| Tilmanocept | None of these genes | Approved |
| Toripalimab | None of these genes | Approved |
| Trametinib | None of these genes | Approved |
| Treosulfan | None of these genes | Approved |
| Vemurafenib | None of these genes | Approved |
| Aldesleukin | None of these genes | Phase 3 |
| .Alpha.-Pyrrolidinononanophenone | None of these genes | Phase 3 |
| Atezolizumab | None of these genes | Phase 3 |
| Belzupacap Sarotalocan | None of these genes | Phase 3 |
| Bempegaldesleukin | None of these genes | Phase 3 |
| Brenetafusp | None of these genes | Phase 3 |
| Camrelizumab | None of these genes | Phase 3 |
| Carboplatin | None of these genes | Phase 3 |
| Cemiplimab | None of these genes | Phase 3 |
| Cisplatin | None of these genes | Phase 3 |
| Cytarabine | None of these genes | Phase 3 |
| Elesclomol | None of these genes | Phase 3 |
| Epacadostat | None of these genes | Phase 3 |
| Favezelimab | None of these genes | Phase 3 |
| Fianlimab | None of these genes | Phase 3 |
| Fotemustine | None of these genes | Phase 3 |
| Gp-100 Antigen | None of these genes | Phase 3 |
| Histamine | None of these genes | Phase 3 |
| Ingenol Mebutate | None of these genes | Phase 3 |
| Interferon Alfa | None of these genes | Phase 3 |
| Interferon Alfa-2a | None of these genes | Phase 3 |
| Interferon Gamma-1b | None of these genes | Phase 3 |
| L19il2 | None of these genes | Phase 3 |
| Lenalidomide | None of these genes | Phase 3 |
| Lenvatinib | None of these genes | Phase 3 |
| Lifileucel | None of these genes | Phase 3 |
| Linrodostat | None of these genes | Phase 3 |
| Lutetium Oxodotreotide | None of these genes | Phase 3 |
| Masitinib | None of these genes | Phase 3 |
| Melphalan | None of these genes | Phase 3 |
| Mitumomab | None of these genes | Phase 3 |
| Molgramostim | None of these genes | Phase 3 |
| Naporafenib | None of these genes | Phase 3 |
| Novaferon | None of these genes | Phase 3 |
| Nurulimab | None of these genes | Phase 3 |
| Oblimersen | None of these genes | Phase 3 |
| Oblimersen Sodium | None of these genes | Phase 3 |
| Olaparib | None of these genes | Phase 3 |
| Onfekafusp Alfa | None of these genes | Phase 3 |
| Osimertinib | None of these genes | Phase 3 |
| Paclitaxel | None of these genes | Phase 3 |
| Paclitaxel Docosahexaenoic Acid | None of these genes | Phase 3 |
| Peginterferon Alfa-2a | None of these genes | Phase 3 |
| Prolgolimab | None of these genes | Phase 3 |
| Pucotenlimab | None of these genes | Phase 3 |
| Qs-21 | None of these genes | Phase 3 |
| Regramostim | None of these genes | Phase 3 |
| Rivoceranib | None of these genes | Phase 3 |
| Ropeginterferon Alfa-2b | None of these genes | Phase 3 |
| Sargramostim | None of these genes | Phase 3 |
| Selumetinib | None of these genes | Phase 3 |
| Seviprotimut-L | None of these genes | Phase 3 |
| Sorafenib | None of these genes | Phase 3 |
| Spartalizumab | None of these genes | Phase 3 |
| Temozolomide | None of these genes | Phase 3 |
| Teplizumab | None of these genes | Phase 3 |
| Tilsotolimod | None of these genes | Phase 3 |
| Tremelimumab | None of these genes | Phase 3 |
| Tucidinostat | None of these genes | Phase 3 |
| Tunlametinib | None of these genes | Phase 3 |
| Velimogene Aliplasmid | None of these genes | Phase 3 |
| Vibostolimab | None of these genes | Phase 3 |
| Vinblastine | None of these genes | Phase 3 |
| Vitespen | None of these genes | Phase 3 |
| Vusolimogene Oderparepvec | None of these genes | Phase 3 |
| Chembl569766 | None of these genes | Phase 2/3 |
| Fx-005 | None of these genes | Phase 2/3 |
| Indoximod | None of these genes | Phase 2/3 |
| Trabedersen | None of these genes | Phase 2/3 |
| Vidutolimod | None of these genes | Phase 2/3 |
| 4-Demethyl-4-Cholesteryloxycarbonylpenclomedine | None of these genes | Phase 2 |
| 6-O-Benzylguanine | None of these genes | Phase 2 |
| Abemaciclib | None of these genes | Phase 2 |
| Abt-510 | None of these genes | Phase 2 |
| Abx-Il8 | None of these genes | Phase 2 |
| Acetaminophen | None of these genes | Phase 2 |
| Acitretin | None of these genes | Phase 2 |
| Aflibercept | None of these genes | Phase 2 |
| Agatolimod | None of these genes | Phase 2 |
| Alemtuzumab | None of these genes | Phase 2 |
| Aluminum Hydroxide | None of these genes | Phase 2 |
| Alvocidib | None of these genes | Phase 2 |
| An-9 | None of these genes | Phase 2 |
| Aspirin | None of these genes | Phase 2 |
| Astuprotimut-R | None of these genes | Phase 2 |
| Autogene Cevumeran | None of these genes | Phase 2 |
| Avadomide | None of these genes | Phase 2 |
| Avelumab | None of these genes | Phase 2 |
| Aviscumine | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Azacitidine | None of these genes | Phase 2 |
| Bardoxolone Methyl | None of these genes | Phase 2 |
| Belapectin | None of these genes | Phase 2 |
| Belvarafenib | None of these genes | Phase 2 |
| Bevacizumab | None of these genes | Phase 2 |
| Bi-2536 | None of these genes | Phase 2 |
| Bleomycin | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Bosentan | None of these genes | Phase 2 |
| Budesonide | None of these genes | Phase 2 |
| Buparlisib | None of these genes | Phase 2 |
| Cabozantinib | None of these genes | Phase 2 |
| Cadonilimab | None of these genes | Phase 2 |
| Canakinumab | None of these genes | Phase 2 |
| Canerpaturev | None of these genes | Phase 2 |
| Capmatinib | None of these genes | Phase 2 |
| Carmustine | None of these genes | Phase 2 |
| Catequentinib | None of these genes | Phase 2 |
| Cd40 Ligand | None of these genes | Phase 2 |
| Cdx-301 | None of these genes | Phase 2 |
| Cediranib | None of these genes | Phase 2 |
| Celecoxib | None of these genes | Phase 2 |
| Ceralasertib | None of these genes | Phase 2 |
| Ceritinib | None of these genes | Phase 2 |
| Cifurtilimab | None of these genes | Phase 2 |
| Cilengitide | None of these genes | Phase 2 |
| Cimetidine | None of these genes | Phase 2 |
| Cobolimab | None of these genes | Phase 2 |
| Cp-461 | None of these genes | Phase 2 |
| Cpg-52852 | None of these genes | Phase 2 |
| Crizanlizumab | None of these genes | Phase 2 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 2 |
| Cyclosporine | None of these genes | Phase 2 |
| Daclizumab | None of these genes | Phase 2 |
| Dactinomycin | None of these genes | Phase 2 |
| Daporinad | None of these genes | Phase 2 |
| Dasatinib Anhydrous | None of these genes | Phase 2 |
| Denenicokin | None of these genes | Phase 2 |
| Denileukin Diftitox | None of these genes | Phase 2 |
| Denosumab | None of these genes | Phase 2 |
| Dienestrol | None of these genes | Phase 2 |
| Dinaciclib | None of these genes | Phase 2 |
| Disitamab Vedotin | None of these genes | Phase 2 |
| Disulfiram | None of these genes | Phase 2 |
| Docetaxel Anhydrous | None of these genes | Phase 2 |
| Domvanalimab | None of these genes | Phase 2 |
| Dorgenmeltucel-L | None of these genes | Phase 2 |
| Dostarlimab | None of these genes | Phase 2 |
| Doxorubicin | None of these genes | Phase 2 |
| Durvalumab | None of these genes | Phase 2 |
| E-7016 | None of these genes | Phase 2 |
| Ecromeximab | None of these genes | Phase 2 |
| Elacytarabine | None of these genes | Phase 2 |
| Emd-273063 | None of these genes | Phase 2 |
| Endostatin | None of these genes | Phase 2 |
| Endostatin, N-Terminal-Mggshhhhh | None of these genes | Phase 2 |
| Enfortumab Vedotin | None of these genes | Phase 2 |
| Enomimeran | None of these genes | Phase 2 |
| Ensartinib | None of these genes | Phase 2 |
| Entinostat | None of these genes | Phase 2 |
| Entrectinib | None of these genes | Phase 2 |
| Epirubicin | None of these genes | Phase 2 |
| Erlotinib | None of these genes | Phase 2 |
| Etaracizumab | None of these genes | Phase 2 |
| Etimupepimut | None of these genes | Phase 2 |
| Everolimus | None of these genes | Phase 2 |
| Evofosfamide | None of these genes | Phase 2 |
| Famitinib | None of these genes | Phase 2 |
| Filgrastim | None of these genes | Phase 2 |
| Fludarabine | None of these genes | Phase 2 |
| Fludarabine Phosphate | None of these genes | Phase 2 |
| Fructose | None of these genes | Phase 2 |
| Ganetespib | None of these genes | Phase 2 |
| Gebasaxturev | None of these genes | Phase 2 |
| Gemcitabine | None of these genes | Phase 2 |
| Gindameran | None of these genes | Phase 2 |
| Glembatumumab Vedotin | None of these genes | Phase 2 |
| Golnerminogene Pradenovec | None of these genes | Phase 2 |
| Guadecitabine | None of these genes | Phase 2 |
| Hiltonol | None of these genes | Phase 2 |
| Human Immunoglobulin G | None of these genes | Phase 2 |
| Hydroxychloroquine | None of these genes | Phase 2 |
| Iboctadekin | None of these genes | Phase 2 |
| Ibrutinib | None of these genes | Phase 2 |
| Ieramilimab | None of these genes | Phase 2 |
| Imatinib | None of these genes | Phase 2 |
| Imsapepimut | None of these genes | Phase 2 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 2 |
| Indisulam | None of these genes | Phase 2 |
| Indomethacin | None of these genes | Phase 2 |
| Infigratinib | None of these genes | Phase 2 |
| Infliximab | None of these genes | Phase 2 |
| Interferon | None of these genes | Phase 2 |
| Interleukin-12 Human Recombinant | None of these genes | Phase 2 |
| Intismeran Autogene | None of these genes | Phase 2 |
| Irofulven | None of these genes | Phase 2 |
| Iron Dextran | None of these genes | Phase 2 |
| Ispinesib | None of these genes | Phase 2 |
| Ixabepilone | None of these genes | Phase 2 |
| Karenitecin | None of these genes | Phase 2 |
| Keyhole Limpet Hemocyanin | None of these genes | Phase 2 |
| Ladiratuzumab Vedotin | None of these genes | Phase 2 |
| Lapatinib | None of these genes | Phase 2 |
| Letetresgene Autoleucel | None of these genes | Phase 2 |
| Leuprolide | None of these genes | Phase 2 |
| Lomustine | None of these genes | Phase 2 |
| Lovastatin | None of these genes | Phase 2 |
| Medi-6469 | None of these genes | Phase 2 |
| Melanoma-Associated Antigen 3 | None of these genes | Phase 2 |
| Melatonin | None of these genes | Phase 2 |
| Metformin | None of these genes | Phase 2 |
| Methylprednisolone | None of these genes | Phase 2 |
| Mirdametinib | None of these genes | Phase 2 |
| Mk-2206 | None of these genes | Phase 2 |
| Muparfostat | None of these genes | Phase 2 |
| Muromonab-Cd3 | None of these genes | Phase 2 |
| Mycophenolate Mofetil | None of these genes | Phase 2 |
| Naltrexone | None of these genes | Phase 2 |
| Nelfinavir | None of these genes | Phase 2 |
| Nilotinib | None of these genes | Phase 2 |
| Niraparib | None of these genes | Phase 2 |
| Ofatumumab | None of these genes | Phase 2 |
| Ontasameran | None of these genes | Phase 2 |
| Ontuxizumab | None of these genes | Phase 2 |
| Ovemotide | None of these genes | Phase 2 |
| P-276-00 | None of these genes | Phase 2 |
| Palbociclib | None of these genes | Phase 2 |
| Patritumab Deruxtecan | None of these genes | Phase 2 |
| Patupilone | None of these genes | Phase 2 |
| Pazopanib | None of these genes | Phase 2 |
| Pegargiminase | None of these genes | Phase 2 |
| Pelareorep | None of these genes | Phase 2 |
| Pemetrexed | None of these genes | Phase 2 |
| Penpulimab | None of these genes | Phase 2 |
| Pentamidine | None of these genes | Phase 2 |
| Perifosine | None of these genes | Phase 2 |
| Pidilizumab | None of these genes | Phase 2 |
| Pixatimod | None of these genes | Phase 2 |
| Platinum | None of these genes | Phase 2 |
| Plixorafenib | None of these genes | Phase 2 |
| Polidocanol | None of these genes | Phase 2 |
| Prednisone | None of these genes | Phase 2 |
| Propranolol | None of these genes | Phase 2 |
| Psilocybin | None of these genes | Phase 2 |
| Pyrazoloacridine | None of these genes | Phase 2 |
| Raf-265 | None of these genes | Phase 2 |
| Ramucirumab | None of these genes | Phase 2 |
| Rasdegafusp Alfa | None of these genes | Phase 2 |
| Regorafenib | None of these genes | Phase 2 |
| Resiquimod | None of these genes | Phase 2 |
| Retaspimycin | None of these genes | Phase 2 |
| Retlirafusp Alfa | None of these genes | Phase 2 |
| Rg-4733 | None of these genes | Phase 2 |
| Ribociclib | None of these genes | Phase 2 |
| Rigosertib | None of these genes | Phase 2 |
| Riluzole | None of these genes | Phase 2 |
| Rintatolimod | None of these genes | Phase 2 |
| Rituximab | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Rose Bengal Free Acid | None of these genes | Phase 2 |
| Rosiglitazone | None of these genes | Phase 2 |
| Rubitecan | None of these genes | Phase 2 |
| Ruxotemitide | None of these genes | Phase 2 |
| Sagopilone | None of these genes | Phase 2 |
| Saracatinib | None of these genes | Phase 2 |
| Sarilumab | None of these genes | Phase 2 |
| Selinexor | None of these genes | Phase 2 |
| Selvigaltin | None of these genes | Phase 2 |
| Semaxanib | None of these genes | Phase 2 |
| Sepantronium | None of these genes | Phase 2 |
| Sintilimab | None of these genes | Phase 2 |
| Sipuleucel-T | None of these genes | Phase 2 |
| Sirolimus | None of these genes | Phase 2 |
| Sitravatinib | None of these genes | Phase 2 |
| Sodium Chloride | None of these genes | Phase 2 |
| Sotigalimab | None of these genes | Phase 2 |
| Sulindac | None of these genes | Phase 2 |
| Sunitinib | None of these genes | Phase 2 |
| Suratadenoturev | None of these genes | Phase 2 |
| Talabostat | None of these genes | Phase 2 |
| Talazoparib | None of these genes | Phase 2 |
| Tamoxifen | None of these genes | Phase 2 |
| Tanespimycin | None of these genes | Phase 2 |
| Tasidotin | None of these genes | Phase 2 |
| Tasisulam | None of these genes | Phase 2 |
| Tavokinogene Telseplasmid | None of these genes | Phase 2 |
| Tazemetostat | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Tesetaxel | None of these genes | Phase 2 |
| Thalidomide | None of these genes | Phase 2 |
| Thymalfasin | None of these genes | Phase 2 |
| Tigilanol Tiglate | None of these genes | Phase 2 |
| Tilsotolimod Sodium | None of these genes | Phase 2 |
| Tiomolibdate Choline | None of these genes | Phase 2 |
| Tipifarnib | None of these genes | Phase 2 |
| Tiragolumab | None of these genes | Phase 2 |
| Tislelizumab | None of these genes | Phase 2 |
| Tivumecirnon | None of these genes | Phase 2 |
| Tobemstomig | None of these genes | Phase 2 |
| Tocilizumab | None of these genes | Phase 2 |
| Tovorafenib | None of these genes | Phase 2 |
| Tretinoin | None of these genes | Phase 2 |
| Troculeucel | None of these genes | Phase 2 |
| Troriluzole | None of these genes | Phase 2 |
| Tt-232 | None of these genes | Phase 2 |
| Tyrosinase | None of these genes | Phase 2 |
| Tyrosine | None of these genes | Phase 2 |
| Ucn-01 | None of these genes | Phase 2 |
| Ulixertinib | None of these genes | Phase 2 |
| Uprosertib | None of these genes | Phase 2 |
| Urelumab | None of these genes | Phase 2 |
| Vactosertib | None of these genes | Phase 2 |
| Varlilumab | None of these genes | Phase 2 |
| Veliparib | None of these genes | Phase 2 |
| Vibosameran | None of these genes | Phase 2 |
| Vinorelbine | None of these genes | Phase 2 |
| Volociximab | None of these genes | Phase 2 |
| Vorinostat | None of these genes | Phase 2 |
| Yh-003 | None of these genes | Phase 2 |
| Zanolimumab | None of these genes | Phase 2 |
| Zimberelimab | None of these genes | Phase 2 |
| Zinc Acetate Anhydrous | None of these genes | Phase 2 |
| Zinc Sulfate | None of these genes | Phase 2 |
| Adh-1 | None of these genes | Phase 1/2 |
| Allantoin | None of these genes | Phase 1/2 |
| Alrizomadlin | None of these genes | Phase 1/2 |
| Antilymphocyte Immunoglobulin (Horse) | None of these genes | Phase 1/2 |
| Avutometinib | None of these genes | Phase 1/2 |
| Bcg Live | None of these genes | Phase 1/2 |
| Bcg Vaccine | None of these genes | Phase 1/2 |
| Bemcentinib | None of these genes | Phase 1/2 |
| Bexmarilimab | None of these genes | Phase 1/2 |
| Bintrafusp Alfa | None of these genes | Phase 1/2 |
| Bocodepsin | None of these genes | Phase 1/2 |
| Bq 788 | None of these genes | Phase 1/2 |
| Calcitriol | None of these genes | Phase 1/2 |
| Capecitabine | None of these genes | Phase 1/2 |
| Cavrotolimod | None of these genes | Phase 1/2 |
| Cd24fc | None of these genes | Phase 1/2 |
| Cdx-1140 | None of these genes | Phase 1/2 |
| Cdx-3379 | None of these genes | Phase 1/2 |
| Cetrelimab | None of these genes | Phase 1/2 |
| Chlorotoxin | None of these genes | Phase 1/2 |
| Dapansutrile | None of these genes | Phase 1/2 |
| Davanat | None of these genes | Phase 1/2 |
| Decitabine | None of these genes | Phase 1/2 |
| Defactinib | None of these genes | Phase 1/2 |
| Dexamethasone | None of these genes | Phase 1/2 |
| Dovitinib | None of these genes | Phase 1/2 |
| Doxycycline Anhydrous | None of these genes | Phase 1/2 |
| Duvelisib | None of these genes | Phase 1/2 |
| E-7386 | None of these genes | Phase 1/2 |
| Edodekin Alfa | None of these genes | Phase 1/2 |
| Efineptakin Alfa | None of these genes | Phase 1/2 |
| Eftilagimod Alfa | None of these genes | Phase 1/2 |
| Eribulin | None of these genes | Phase 1/2 |
| Etoricoxib | None of these genes | Phase 1/2 |
| Evalstotug | None of these genes | Phase 1/2 |
| F16il2 | None of these genes | Phase 1/2 |
| Fluorouracil | None of these genes | Phase 1/2 |
| Fluzoparib | None of these genes | Phase 1/2 |
| Ganitumab | None of these genes | Phase 1/2 |
| Gimistotug | None of these genes | Phase 1/2 |
| Golvatinib | None of these genes | Phase 1/2 |
| Hyaluronidase (Human Recombinant) | None of these genes | Phase 1/2 |
| Ifebemtinib | None of these genes | Phase 1/2 |
| Ifinatamab Deruxtecan | None of these genes | Phase 1/2 |
| Imc-Cs4 | None of these genes | Phase 1/2 |
| Imcnyeso | None of these genes | Phase 1/2 |
| Imexon | None of these genes | Phase 1/2 |
| Imiquimod | None of these genes | Phase 1/2 |
| Interleukin 15, Recombinant Non-Glycosylated | None of these genes | Phase 1/2 |
| Intetumumab | None of these genes | Phase 1/2 |
| Ipatasertib | None of these genes | Phase 1/2 |
| Ismidenon | None of these genes | Phase 1/2 |
| Ivuxolimab | None of these genes | Phase 1/2 |
| Lemzoparlimab | None of these genes | Phase 1/2 |
| Lenograstim | None of these genes | Phase 1/2 |
| Leucovorin | None of these genes | Phase 1/2 |
| Mavorixafor | None of these genes | Phase 1/2 |
| Mcs-110 | None of these genes | Phase 1/2 |
| Navitoclax | None of these genes | Phase 1/2 |
| Nelitolimod | None of these genes | Phase 1/2 |
| Nemvaleukin Alfa | None of these genes | Phase 1/2 |
| Nintedanib | None of these genes | Phase 1/2 |
| Nogapendekin Alfa | None of these genes | Phase 1/2 |
| Ny-Eso-1 | None of these genes | Phase 1/2 |
| Obatoclax | None of these genes | Phase 1/2 |
| Omaveloxolone | None of these genes | Phase 1/2 |
| Omega-3-Acid Ethyl Esters | None of these genes | Phase 1/2 |
| Onc-392 | None of these genes | Phase 1/2 |
| Oxaliplatin | None of these genes | Phase 1/2 |
| Panobinostat | None of these genes | Phase 1/2 |
| Pd-360324 | None of these genes | Phase 1/2 |
| Pegfilgrastim | None of these genes | Phase 1/2 |
| Pemvidutide | None of these genes | Phase 1/2 |
| Pexastimogene Devacirepvec | None of these genes | Phase 1/2 |
| Pexidartinib | None of these genes | Phase 1/2 |
| Pexmetinib | None of these genes | Phase 1/2 |
| Pioglitazone | None of these genes | Phase 1/2 |
| Programmed Cell Death 1 Ligand 1 | None of these genes | Phase 1/2 |
| Quavonlimab | None of these genes | Phase 1/2 |
| Recombinant Human Interleukin-15 | None of these genes | Phase 1/2 |
| Resimmune | None of these genes | Phase 1/2 |
| Retifanlimab | None of these genes | Phase 1/2 |
| Rovalpituzumab Tesirine | None of these genes | Phase 1/2 |
| Socazolimab | None of these genes | Phase 1/2 |
| Solnerstotug | None of these genes | Phase 1/2 |
| Sonolisib | None of these genes | Phase 1/2 |
| Tarlatamab | None of these genes | Phase 1/2 |
| Tasadenoturev | None of these genes | Phase 1/2 |
| Telaglenastat | None of these genes | Phase 1/2 |
| Tertomotide | None of these genes | Phase 1/2 |
| Tetanus Toxoid | None of these genes | Phase 1/2 |
| Trastuzumab | None of these genes | Phase 1/2 |
| Trastuzumab Deruxtecan | None of these genes | Phase 1/2 |
| Trofosfamide | None of these genes | Phase 1/2 |
| Utomilumab | None of these genes | Phase 1/2 |
| Valproic Acid | None of these genes | Phase 1/2 |
| Veledimex | None of these genes | Phase 1/2 |
| Verteporfin | None of these genes | Phase 1/2 |
| Verubulin | None of these genes | Phase 1/2 |
| Vevoctadekin | None of these genes | Phase 1/2 |
| Vobramitamab Duocarmazine | None of these genes | Phase 1/2 |
| Xp-102 | None of these genes | Phase 1/2 |
| Abx-Ma1 | None of these genes | Phase 1 |
| Acetazolamide | None of these genes | Phase 1 |
| Adakitug | None of these genes | Phase 1 |
| Adenosine Diphosphate | None of these genes | Phase 1 |
| Alextatug | None of these genes | Phase 1 |
| Alpelisib | None of these genes | Phase 1 |
| Arsenic Trioxide | None of these genes | Phase 1 |
| As-1409 | None of these genes | Phase 1 |
| Asn007 | None of these genes | Phase 1 |
| Balstilimab | None of these genes | Phase 1 |
| Bavituximab | None of these genes | Phase 1 |
| Bavunalimab | None of these genes | Phase 1 |
| Berahyaluronidase Alfa | None of these genes | Phase 1 |
| Betulinic Acid | None of these genes | Phase 1 |
| Bms-936559 | None of these genes | Phase 1 |
| Botensilimab | None of these genes | Phase 1 |
| Bryostatin 1 | None of these genes | Phase 1 |
| Busulfan | None of these genes | Phase 1 |
| Buthionine Sulfoximine | None of these genes | Phase 1 |
| C-188-9 | None of these genes | Phase 1 |
| Cabiralizumab | None of these genes | Phase 1 |
| Cct-3833 | None of these genes | Phase 1 |
| Certolizumab | None of these genes | Phase 1 |
| Cetuximab | None of these genes | Phase 1 |
| Chloroquine | None of these genes | Phase 1 |
| Citarinostat | None of these genes | Phase 1 |
| Claturafenib | None of these genes | Phase 1 |
| Cv-8102 | None of these genes | Phase 1 |
| Dactolisib | None of these genes | Phase 1 |
| Dalpiciclib | None of these genes | Phase 1 |
| Danburstotug | None of these genes | Phase 1 |
| Darovasertib | None of these genes | Phase 1 |
| Digoxin | None of these genes | Phase 1 |
| Dimethyl Sulfoxide | None of these genes | Phase 1 |
| Dky-709 | None of these genes | Phase 1 |
| Doxribtimine | None of these genes | Phase 1 |
| Ds-8273a | None of these genes | Phase 1 |
| Dubermatinib | None of these genes | Phase 1 |
| E-6201 | None of these genes | Phase 1 |
| E-7766 | None of these genes | Phase 1 |
| Eganelisib | None of these genes | Phase 1 |
| Emactuzumab | None of these genes | Phase 1 |
| Enoblituzumab | None of these genes | Phase 1 |
| Etoposide | None of these genes | Phase 1 |
| Exarafenib | None of these genes | Phase 1 |
| Ezabenlimab | None of these genes | Phase 1 |
| Flanvotumab | None of these genes | Phase 1 |
| Fresolimumab | None of these genes | Phase 1 |
| Ganciclovir | None of these genes | Phase 1 |
| Gwn-323 | None of these genes | Phase 1 |
| Hafnium Oxide | None of these genes | Phase 1 |
| Indocyanine Green Acid Form | None of these genes | Phase 1 |
| Inosine | None of these genes | Phase 1 |
| Interferon Alfacon-1 | None of these genes | Phase 1 |
| Interleukin-7 | None of these genes | Phase 1 |
| Ioflubenzamide I 131 | None of these genes | Phase 1 |
| Irinotecan | None of these genes | Phase 1 |
| Isoniazid | None of these genes | Phase 1 |
| Isoproterenol | None of these genes | Phase 1 |
| Itacitinib | None of these genes | Phase 1 |
| Izuralimab | None of these genes | Phase 1 |
| Ka-2507 | None of these genes | Phase 1 |
| Ketoconazole | None of these genes | Phase 1 |
| Lanerkitug | None of these genes | Phase 1 |
| Leflunomide | None of these genes | Phase 1 |
| Lifirafenib | None of these genes | Phase 1 |
| Lps | None of these genes | Phase 1 |
| Marizomib | None of these genes | Phase 1 |
| Medi-3617 | None of these genes | Phase 1 |
| Methotrexate | None of these genes | Phase 1 |
| Methoxsalen | None of these genes | Phase 1 |
| Mgd-009 | None of these genes | Phase 1 |
| Migoprotafib | None of these genes | Phase 1 |
| Mk-8353 | None of these genes | Phase 1 |
| Mocetinostat | None of these genes | Phase 1 |
| Modafinil | None of these genes | Phase 1 |
| Morab-028 | None of these genes | Phase 1 |
| Nanrilkefusp Alfa | None of these genes | Phase 1 |
| Nidanilimab | None of these genes | Phase 1 |
| Numidargistat | None of these genes | Phase 1 |
| Obinutuzumab | None of these genes | Phase 1 |
| Onalespib | None of these genes | Phase 1 |
| Ontorpacept | None of these genes | Phase 1 |
| Pantothenic Acid | None of these genes | Phase 1 |
| Parsaclisib | None of these genes | Phase 1 |
| Pasireotide | None of these genes | Phase 1 |
| Pepinemab | None of these genes | Phase 1 |
| Perflutren | None of these genes | Phase 1 |
| Pevonedistat | None of these genes | Phase 1 |
| Pf-06688992 | None of these genes | Phase 1 |
| Phenformin | None of these genes | Phase 1 |
| Plozalizumab | None of these genes | Phase 1 |
| Porustobart | None of these genes | Phase 1 |
| Pti-6d2 188re | None of these genes | Phase 1 |
| Rg-7256 | None of these genes | Phase 1 |
| Rg-7636 | None of these genes | Phase 1 |
| Rifampin | None of these genes | Phase 1 |
| Ro-4987655 | None of these genes | Phase 1 |
| Sar-260301 | None of these genes | Phase 1 |
| Sar-439459 | None of these genes | Phase 1 |
| Sasanlimab | None of these genes | Phase 1 |
| Selicrelumab | None of these genes | Phase 1 |
| Sephb4-Hsa | None of these genes | Phase 1 |
| Serplulimab | None of these genes | Phase 1 |
| Simlukafusp Alfa | None of these genes | Phase 1 |
| Sodium Stibogluconate | None of these genes | Phase 1 |
| Sx-682 | None of these genes | Phase 1 |
| Tacrolimus Anhydrous | None of these genes | Phase 1 |
| Tak-733 | None of these genes | Phase 1 |
| Tavolimab | None of these genes | Phase 1 |
| Tebotelimab | None of these genes | Phase 1 |
| Tetrahydrouridine | None of these genes | Phase 1 |
| Tetraxetan | None of these genes | Phase 1 |
| Tifcemalimab | None of these genes | Phase 1 |
| Tilarginine | None of these genes | Phase 1 |
| Tinlorafenib | None of these genes | Phase 1 |
| Tinostamustine | None of these genes | Phase 1 |
| Tivantinib | None of these genes | Phase 1 |
| Trebananib | None of these genes | Phase 1 |
| Trientine | None of these genes | Phase 1 |
| Trx-518 | None of these genes | Phase 1 |
| Tumor Necrosis Factor Receptor Superfamily Member 9 | None of these genes | Phase 1 |
| Vedolizumab | None of these genes | Phase 1 |
| Vincristine | None of these genes | Phase 1 |
| Voruciclib | None of these genes | Phase 1 |
| Vudalimab | None of these genes | Phase 1 |
| Wp 1066 | None of these genes | Phase 1 |
| Xl-281 | None of these genes | Phase 1 |
| Xl-888 | None of these genes | Phase 1 |
| Genistein | None of these genes | Early phase 1 |
| Gilvetmab | None of these genes | Early phase 1 |
| Imc-Gp100 | None of these genes | Early phase 1 |
| Narciclasine | None of these genes | Investigational new drug |
| Budigalimab | None of these genes | Unknown |
| Fruquintinib | None of these genes | Unknown |
| Withaferin A | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.